Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

24.01.14 | Tyratech to sell Vamousse through Walmart

Tyratech have recently announced a deal to sell Vamousse, their preventative head lice treatment product, through Walmart in the US.

07.10.13 | Tyratech discussing US distribution of head lice products

Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.

06.06.13 | Eden Research Licence Agreement

Eden Research has announced an agreement with Neo-Pharma Innovations to develop their terpene-based head lice treatment for commercial sale.

14.12.12 | New funding and efficacy data for Hatchtech

Hatchtech, Pty Ltd have announced the completion of their financing round and published new data on the active ingredient in their DeOvo pediculicide product.

13.12.12 | TyraTech receives Product Registration in UK

TyraTech, Inc, has received notification from the UK regualtory body that their VaMOUSSE!™ head lice product has been registered as a medical device.

20.03.14 | Lice resistance research

Two new papers on the response of lice and nits to common treatments have recently been published.

20.03.14 | Efficacy of herbal shampoos against head lice

 A new study has analysed a range of herbal shampoos for their ability to kill head lice.

20.02.14 | ICP5 Call for Abstracts

The International Society of Phthirapterists invites you to register and
submit abstracts for the 5th International Conference on Phthiraptera,
August 2 - 7, 2014 at Canyons Resort in Park City Utah, USA.

31.10.13 | Best Yet! head-lice marketing requires FDA pre-approval

A recent decision by the US Federal Trade Commission (FTC) requires that advertising claims by makers of Best Yet! head lice products receive Food and Drug Administration (FDA) pre-approval.

31.10.13 | Survey on Italian pediatrician head lice treatment preferences

A recently published survey of Italian pediatricians shows that malathion and pyrethroids are the leading pediculicides of choice for lice infections.

morenews-ind.png morenews-sci.png
  • Scientific News
  • Clinical Trials
  • Regulatory News
  • Company News
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Licecomb Engineering

Join us on Twitter

pediculosisnews
pediculosisnews FDA insists lice treatment advertising claims require their approval first. http://www.pediculosis.com/news/scientific-news/regulatory-news/111-best-yet-head-lice-marketing-requires-fda-pre-approval.html
10:42AM Oct 31
pediculosisnews
pediculosisnews Eden Research has announced an agreement to develop their terpene-based head lice treatment for sale http://www.pediculosis.com/news/industry-news/company-news/106-eden-research-licence-agreement.html
10:16AM Jun 13

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved